tiprankstipranks
Trending News
More News >
Generic Sweden AB (SE:GENI)
:GENI
Sweden Market

Generic Sweden AB (GENI) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

GENI Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Generic
Sweden AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GENI Stock 12 Month Forecast

There Are No Analyst Ratings for SE:GENI In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GENI Financial Forecast

GENI Earnings Forecast

Next quarter’s earnings estimate for GENI is kr0.65 with a range of kr0.65 to kr0.65. The previous quarter’s EPS was kr0.66. GENI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 66.27% of the time in the same period. In the last calendar year GENI has Performed in-line its overall industry.
Next quarter’s earnings estimate for GENI is kr0.65 with a range of kr0.65 to kr0.65. The previous quarter’s EPS was kr0.66. GENI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 66.27% of the time in the same period. In the last calendar year GENI has Performed in-line its overall industry.

GENI Sales Forecast

Next quarter’s sales forecast for GENI is kr49.80M with a range of kr49.80M to kr49.80M. The previous quarter’s sales results were kr45.34M. GENI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 70.06% of the time in the same period. In the last calendar year GENI has Performed in-line its overall industry.
Next quarter’s sales forecast for GENI is kr49.80M with a range of kr49.80M to kr49.80M. The previous quarter’s sales results were kr45.34M. GENI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 70.06% of the time in the same period. In the last calendar year GENI has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on SE:GENI
TipRanks - OpenAI
TipRanks - OpenAI
kr54
Buy
16.25%
Upside
Initiated
01/04/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on SE:GENI
TipRanks - OpenAI
TipRanks - OpenAI
kr54
Buy
16.25%
Upside
Initiated
01/04/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Technology Sector
Find stocks in the Technology sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Generic Sweden AB

3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.50%
initiated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.50% per trade.
1 Year
OpenAI Technology EUTipRanks - OpenAI
Success Rate
1/1 ratings generated profit
0%
Average Return
+0.10%
initiated a buy rating 9 days ago
Copying OpenAI Technology EU's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of +0.10% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.50%
initiated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -0.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GENI Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, GENI has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GENI average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

GENI Stock Forecast FAQ

What is SE:GENI’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:GENI’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:GENI, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Generic Sweden AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Generic Sweden AB’s share price target?
      Currently, no data Available
      What do analysts say about Generic Sweden AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Generic Sweden AB?
      To buy shares of SE:GENI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.